...
首页> 外文期刊>The international journal of biochemistry and cell biology >Integrated genomics of chemotherapy resistant ovarian cancer: a role for extracellular matrix, TGFbeta and regulating microRNAs.
【24h】

Integrated genomics of chemotherapy resistant ovarian cancer: a role for extracellular matrix, TGFbeta and regulating microRNAs.

机译:化疗耐药性卵巢癌的综合基因组学:细胞外基质,TGFbeta和调控microRNA的作用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Epithelial ovarian cancer is the sixth most common cancer in women worldwide and the most important cause of death from gynaecological cancers in the Western world. Our explorative pathway analysis on seven published gene-sets associated with platinum resistance in ovarian cancer reveals TP53 and transforming growth factor beta as key genes. Furthermore, the extracellular matrix was associated with chemotherapy resistance in ovarian cancer as well as endocrine resistance in breast cancer. Pathway analysis again revealed transforming growth factor beta as a key gene regulating extracellular matrix gene expression. A model is presented based on literature linking transforming growth factor beta, extracellular matrix, integrin signalling, epithelial to mesenchymal transition and regulating microRNAs with a (bivalent) role in chemotherapy response.
机译:上皮性卵巢癌是全世界女性中第六大最常见的癌症,也是西方世界妇科癌症死亡的最重要原因。我们对七个已发表的与卵巢癌铂耐药相关的基因组进行的探索性途径分析显示,TP53和转化生长因子β是关键基因。此外,细胞外基质与卵巢癌的化学疗法抗性以及乳腺癌的内分泌抗性有关。途径分析再次表明转化生长因子β是调节细胞外基质基因表达的关键基因。根据文献提出了一个模型,该文献将转化生长因子β,细胞外基质,整联蛋白信号传导,上皮向间充质转化以及调节在(2价)化学反应中起作用的微RNA链接在一起。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号